Artelo Biosciences, Inc. (ARTL) Misses Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts ARTL Hot Sheet
Join SI Premium – FREE
Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.83), $0.18 worse than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays sees global expansion intact, warns against market complacency
- SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
- KKR reports over $900M in Q2 monetization income through June 24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
